Almerico Marruchella
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Almerico Marruchella has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
- Alberto Pesci
Respiratory Unit, University of Milan-Bicocca, S. Gerardo Hospital, 20900 Monza, Italy
1 shared publication - Andrea Gori
Department of Infectious Diseases, ASST Fatebenefratelli Sacco University Hospital , Milan
1 shared publication - Anna Festa
Medical Technology Laboratory, IRCCS Istituto Ortopedico Rizzoli, 40136 Bologna, Italy
1 shared publication - Anna Stainer
Department of Biomedical Sciences, Humanitas University, Milan, Italy
1 shared publication Cesare Saltini
University of Rome Tor Vergata
1 shared publicationCosimo Franco
Unità Operativa di Pneumologia, Ospedale Civile, Piacenza, Italy
1 shared publication
Latest Publications
- Open Access
- 16 November 2016
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 17 (11) , 1913
Characterizing Non-Tuberculous Mycobacteria Infection in Bronchiectasis
Chronic airway infection is a key aspect of the pathogenesis of bronchiectasis. A growing interest has been raised on non-tuberculous mycobacteria (NTM) infection. We aimed at describing the clinical characteristics, diagnostic process, therapeutic options and outcomes of bronchiectasis patients with pulmonary NTM (pNTM) disease. This was a prospective, observational study enrolling 261 adult bronchiectasis patients during the stable state at the San Gerardo Hospital, Monza, Italy, from 2012 to 2015. Three groups were identified: pNTM disease; chronic P. aeruginosa infection; chronic infection due to bacteria other than P. aeruginosa. NTM were isolated in 32 (12%) patients, and among them, a diagnosis of pNTM disease was reached in 23 cases. When compared to chronic P. aeruginosa infection, patients with pNTM were more likely to have cylindrical bronchiectasis and a “tree-in-bud” pattern, a history of weight loss, a lower disease severity and a lower number of pulmonary exacerbations. Among pNTM patients who started treatment, 68% showed a radiological improvement, and 37% achieved culture conversion without recurrence, while 21% showed NTM isolation recurrence. NTM isolation seems to be a frequent event in bronchiectasis patients, and few parameters might help to suspect NTM infection. Treatment indications and monitoring still remain an important area for future research.
- 16 November 2016
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 17 (11) , 1913
Open AccessCharacterizing Non-Tuberculous Mycobacteria Infection in Bronchiectasis
Chronic airway infection is a key aspect of the pathogenesis of bronchiectasis. A growing interest has been raised on non-tuberculous mycobacteria (NTM) infection. We aimed at describing the clinical characteristics, diagnostic process, therapeutic options and outcomes of bronchiectasis patients with pulmonary NTM (pNTM) disease. This was a prospective, observational study enrolling 261 adult bronchiectasis patients during the stable state at the San Gerardo Hospital, Monza, Italy, from 2012 to 2015. Three groups were identified: pNTM disease; chronic P. aeruginosa infection; chronic infection due to bacteria other than P. aeruginosa. NTM were isolated in 32 (12%) patients, and among them, a diagnosis of pNTM disease was reached in 23 cases. When compared to chronic P. aeruginosa infection, patients with pNTM were more likely to have cylindrical bronchiectasis and a “tree-in-bud” pattern, a history of weight loss, a lower disease severity and a lower number of pulmonary exacerbations. Among pNTM patients who started treatment, 68% showed a radiological improvement, and 37% achieved culture conversion without recurrence, while 21% showed NTM isolation recurrence. NTM isolation seems to be a frequent event in bronchiectasis patients, and few parameters might help to suspect NTM infection. Treatment indications and monitoring still remain an important area for future research.
- 30 June 2006
- Published by S. Karger AG in Respiration
- Vol. 75 (4) , 461-465
Molecular Diagnosis of Fatal Nocardia farcinica Pneumonia in an HIV-Negative Patient
Nocardiosis is a rare and potentially life-threatening infection caused by several species of the Nocardia genus. Most cases occur in immunocompromised patients, and a delay in establishing the diagnosis is common due to the non-specific clinical presentations and the difficulty in cultivating Nocardia. Although the majority of pulmonary nocardiosis cases are caused by Nocardia asteroides, cases of human infection due to N. farcinica are increasingly diagnosed due to recent developments in taxonomy and diagnostic methods. N. farcinica is a separate species from N. asteroides and appears to be more virulent and resistant to antibiotics. Herein, we describe the case of a 65-year-old HIV-negative immunocompromised patient with a fulminant bilateral pulmonary nocardiosis while on empirical treatment with trimethoprim/sulfamethoxazole and imipenem. Post-mortem diagnosis of N. farcinica infection was performed by means of DNA amplification and sequencing of the 65-kDa bacterial heat shock protein.
- 30 June 2006
- Published by S. Karger AG in Respiration
- Vol. 75 (4) , 461-465
Molecular Diagnosis of Fatal Nocardia farcinica Pneumonia in an HIV-Negative Patient
Nocardiosis is a rare and potentially life-threatening infection caused by several species of the Nocardia genus. Most cases occur in immunocompromised patients, and a delay in establishing the diagnosis is common due to the non-specific clinical presentations and the difficulty in cultivating Nocardia. Although the majority of pulmonary nocardiosis cases are caused by Nocardia asteroides, cases of human infection due to N. farcinica are increasingly diagnosed due to recent developments in taxonomy and diagnostic methods. N. farcinica is a separate species from N. asteroides and appears to be more virulent and resistant to antibiotics. Herein, we describe the case of a 65-year-old HIV-negative immunocompromised patient with a fulminant bilateral pulmonary nocardiosis while on empirical treatment with trimethoprim/sulfamethoxazole and imipenem. Post-mortem diagnosis of N. farcinica infection was performed by means of DNA amplification and sequencing of the 65-kDa bacterial heat shock protein.
- 1 September 2002
- Vol. 44 (3) , 257-60
Reliability of bronchoalveolar lavage in the routine clinical assessment of patients with sarcoidosis. A retrospective analysis.
The aim of the study was to evaluate the reliability of bronchoalveolar lavage in the routine clinical assessment of patients with sarcoidosis. retrospective analysis. 2 Divisions of Respiratory Medicine, both in the context of a public general hospital (Ospedale Morelli, Sondalo, Italy and Ospedale Civile, Piacenza, Italy). 89 patients with definitely diagnosed diffuse infiltrative lung disease, who underwent bronchoalveolar lavage as part of their initial diagnostic work-up in the period 1991-2001. Fifty-one of them had biopsy-proven sarcoidosis. Diagnostic procedures were: transbronchial lung biopsy (n=26), bronchial biopsy (n=11), skin biopsy (n=6), surgical lung biopsy (n=4), superficial lymph node biopsy (n=3), mediastinal lymph node biopsy (n=1). In 38 patients various interstitial lung diseases were diagnosed, according to established criteria. we compared the percentage of BAL lymphocytes and CD4/CD8 ratio in the 2 groups. Sensitivity, specificity, positive and negative predictive value of BAL parameters were calculated with a cut-off value of 28% for BAL lymphocytes and 3.5 for CD4/CD8 ratio. The percentage of lymphocytes was similar in the 2 groups (p=0.19); CD4/CD8 ratio was 5.7+/-4.9 in sarcoidosis and 2.0+/-3.3 in the other patients (p=0.0001). BAL CD4/CD8 ratio in sarcoidosis had sensitivity 58%, specificity 86%, positive predictive value 85%, negative predictive value 61%. BAL has a low sensitivity in patients with sarcoidosis; CD4/CD8 ratio >or=3.5 strongly suggests sarcoidosis but is not specific enough if considered alone.
- 1 September 2002
- Vol. 44 (3) , 257-60
Reliability of bronchoalveolar lavage in the routine clinical assessment of patients with sarcoidosis. A retrospective analysis.
The aim of the study was to evaluate the reliability of bronchoalveolar lavage in the routine clinical assessment of patients with sarcoidosis. retrospective analysis. 2 Divisions of Respiratory Medicine, both in the context of a public general hospital (Ospedale Morelli, Sondalo, Italy and Ospedale Civile, Piacenza, Italy). 89 patients with definitely diagnosed diffuse infiltrative lung disease, who underwent bronchoalveolar lavage as part of their initial diagnostic work-up in the period 1991-2001. Fifty-one of them had biopsy-proven sarcoidosis. Diagnostic procedures were: transbronchial lung biopsy (n=26), bronchial biopsy (n=11), skin biopsy (n=6), surgical lung biopsy (n=4), superficial lymph node biopsy (n=3), mediastinal lymph node biopsy (n=1). In 38 patients various interstitial lung diseases were diagnosed, according to established criteria. we compared the percentage of BAL lymphocytes and CD4/CD8 ratio in the 2 groups. Sensitivity, specificity, positive and negative predictive value of BAL parameters were calculated with a cut-off value of 28% for BAL lymphocytes and 3.5 for CD4/CD8 ratio. The percentage of lymphocytes was similar in the 2 groups (p=0.19); CD4/CD8 ratio was 5.7+/-4.9 in sarcoidosis and 2.0+/-3.3 in the other patients (p=0.0001). BAL CD4/CD8 ratio in sarcoidosis had sensitivity 58%, specificity 86%, positive predictive value 85%, negative predictive value 61%. BAL has a low sensitivity in patients with sarcoidosis; CD4/CD8 ratio >or=3.5 strongly suggests sarcoidosis but is not specific enough if considered alone.
- Open Access
- 1 September 2002
- Published by SAGE Publications in Tumori Journal
- Vol. 88 (5) , 414-416
Bleomycin-Induced Upper Lobe Fibrosis: A Case Report
We report a case of late-onset pulmonary fibrosis involving the upper lobes that occurred in a young man treated with bleomycin for mediastinal germ-cell carcinoma. The parenchymal lesions became clinically apparent about two years after chemotherapy had been completed, with a slowly progressive course and sparing the lower lung fields during follow-up. Other possible diagnoses could be excluded on the basis of the patient's clinical history, laboratory tests and pathological findings.
- 1 September 2002
- Published by SAGE Publications in Tumori Journal
- Vol. 88 (5) , 414-416
Open AccessBleomycin-Induced Upper Lobe Fibrosis: A Case Report
We report a case of late-onset pulmonary fibrosis involving the upper lobes that occurred in a young man treated with bleomycin for mediastinal germ-cell carcinoma. The parenchymal lesions became clinically apparent about two years after chemotherapy had been completed, with a slowly progressive course and sparing the lower lung fields during follow-up. Other possible diagnoses could be excluded on the basis of the patient's clinical history, laboratory tests and pathological findings.